Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Autor:
Eric Raspé, Katia Coulonval, Jaime M Pita, Sabine Paternot, Françoise Rothé, Laure Twyffels, Sylvain Brohée, Ligia Craciun, Denis Larsimont, Véronique Kruys, Flavienne Sandras, Isabelle Salmon, Steven Van Laere, Martine Piccart, Michail Ignatiadis, Christos Sotiriou, Pierre P Roger
Publikováno v:
EMBO Molecular Medicine, Vol 9, Iss 8, Pp 1052-1066 (2017)
Abstract Cyclin D‐CDK4/6 are the first CDK complexes to be activated in the G1 phase in response to oncogenic pathways. The specific CDK4/6 inhibitor PD0332991 (palbociclib) was recently approved by the FDA and EMA for treatment of advanced ER‐po
Externí odkaz:
https://doaj.org/article/9b2d45e7df5c4aa580875b12ef3ec949